offline
Bristol-Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates
Bristol-Myers Squibb (BMY) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 11.32%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.09 per share when it actually produced earnings of $1.10, delivering a surprise of 0.92%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Bristol-Myers, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $6.27 billion for the quarter ended June 2019, surpassing the Zacks Consensus Estimate by 3.86%.
...
https://finance.yahoo.com/news/bristol-m...12539.html
![[Bild: BMYc1dl1608.png]](https://finviz.com/publish/072519/BMYc1dl1608.png)
Bristol-Myers Squibb (BMY) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 11.32%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $1.09 per share when it actually produced earnings of $1.10, delivering a surprise of 0.92%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Bristol-Myers, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $6.27 billion for the quarter ended June 2019, surpassing the Zacks Consensus Estimate by 3.86%.
...
https://finance.yahoo.com/news/bristol-m...12539.html
__________________
